Ranitidin-Cophar en es it fr

Ranitidin-Cophar Brand names, Ranitidin-Cophar Analogs

Ranitidin-Cophar Brand Names Mixture

  • Tritec (ranitidine bismuth citrate salt)

Ranitidin-Cophar Chemical_Formula


Ranitidin-Cophar RX_link


Ranitidin-Cophar fda sheet

Ranitidin-Cophar FDA

Ranitidin-Cophar msds (material safety sheet)

Ranitidin-Cophar MSDS

Ranitidin-Cophar Synthesis Reference

B. J. Price et al., U.S. Pat. 4,128,658 (1978)

Ranitidin-Cophar Molecular Weight

314.405 g/mol

Ranitidin-Cophar Melting Point

69-70 oC

Ranitidin-Cophar H2O Solubility

24.7 mg/mL

Ranitidin-Cophar State


Ranitidin-Cophar LogP


Ranitidin-Cophar Dosage Forms

Capsule; Liquid; Solution; Tablet; Syrup

Ranitidin-Cophar Indication

Used in the treatment of peptic ulcer disease (PUD), dyspepsia, stress ulcer prophylaxis, and gastroesophageal reflux disease (GERD).

Ranitidin-Cophar Pharmacology

Ranitidine is a histamine H2-receptor antagonist similar to cimetidine and famotidine. An H2-receptor antagonist, often shortened to H2 antagonist, is a drug used to block the action of histamine on parietal cells in the stomach, decreasing acid production by these cells. These drugs are used in the treatment of dyspepsia, however their use has waned since the advent of the more effective proton pump inhibitors. Like the H1-antihistamines, the H2 antagonists are inverse agonists rather than true receptor antagonists.

Ranitidin-Cophar Absorption

Approximately 50% bioavailability orally.

Ranitidin-Cophar side effects and Toxicity

LD50=77mg/kg (orally in mice). Symptoms of overdose include muscular tremors, vomiting, and rapid respiration.

Ranitidin-Cophar Patient Information


Phenylketonurics: ZANTAC 25 EFFERdose Tablets contain phenylalanine 2.81 mg per 25 mg of ranitidine. ZANTAC 150 EFFERdose Tablets
contain phenylalanine 16.84 mg per 150 mg of ranitidine. ZANTAC EFFERdose Tablets should not be chewed, swallowed whole, or dissolved
on the tongue.

Ranitidin-Cophar Organisms Affected

Humans and other mammals